Education
About Us
Working with TipRanks
Follow Us
P3 Health Partners (PIII)
NASDAQ:PIII
PIII Stock Chart & Stats
$4.12
-$0.01(-4.21%)
At close: 4:00 PM EST
$4.12
-$0.01(-4.21%)
Day’s Range― - ―
52-Week Range$4.01 - $14.50
Previous CloseN/A
Volume132.39K
Average Volume (3M)7.40K
Market Cap
$29.69M
Enterprise Value$216.69M
Total Cash (Recent Filing)$37.71M
Total Debt (Recent Filing)$50.66M
Price to Earnings (P/E)―
Beta0.66
Next Earnings
Mar 26, 2026EPS Estimate
-8.06Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-9.67
Shares Outstanding3,286,465
10 Day Avg. Volume4,406
30 Day Avg. Volume7,400
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)0.43
Price to Sales (P/S)0.02
P/FCF Ratio-0.30
Enterprise Value/Market Cap7.30
Enterprise Value/Revenue0.15
Enterprise Value/Gross Profit0.31
Enterprise Value/Ebitda-1.46
Forecast
1Y Price Target
$10.25Price Target Upside148.79% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
EBITDA Growth StrategiesP3 Health Partners has identified several areas for improvement, including risk-coding, clinical and operational scaling, contract improvements, and product environment enhancements, which are expected to contribute to EBITDA growth.
Financial Performance CommitmentManagement continues to pursue $120m to $170m in EBITDA expansion opportunities, indicating a commitment to improving financial performance.
Operational ImprovementManagement highlighted that the operational improvement plan is now embedded in the business, achieving over $100M in EBITDA improvement year over year.
Bears Say
Earnings ChallengesDespite improvements, significant earnings challenges persist, and margins remain under pressure.
Financial Guidance ReductionThe financial guidance for adjusted EBITDA in 2025 was lowered by $49m at the midpoint, reflecting management's updated expectations.
Unfavorable Financial DevelopmentsThe company experienced an unfavorable intra-year development of approximately $21m, which impacted financial results negatively.
P3 Health Partners News
PIII FAQ
What was P3 Health Partners’s price range in the past 12 months?
P3 Health Partners lowest stock price was $4.01 and its highest was $14.50 in the past 12 months.
What is P3 Health Partners’s market cap?
P3 Health Partners’s market cap is $29.69M.
When is P3 Health Partners’s upcoming earnings report date?
P3 Health Partners’s upcoming earnings report date is Mar 26, 2026 which is in 95 days.
How were P3 Health Partners’s earnings last quarter?
P3 Health Partners released its earnings results on Nov 13, 2025. The company reported -$9.67 earnings per share for the quarter, missing the consensus estimate of -$5.292 by -$4.378.
Is P3 Health Partners overvalued?
According to Wall Street analysts P3 Health Partners’s price is currently Undervalued.
Does P3 Health Partners pay dividends?
P3 Health Partners does not currently pay dividends.
What is P3 Health Partners’s EPS estimate?
P3 Health Partners’s EPS estimate is -8.06.
How many shares outstanding does P3 Health Partners have?
P3 Health Partners has 3,286,465 shares outstanding.
What happened to P3 Health Partners’s price movement after its last earnings report?
P3 Health Partners reported an EPS of -$9.67 in its last earnings report, missing expectations of -$5.292. Following the earnings report the stock price went down -2.286%.
Which hedge fund is a major shareholder of P3 Health Partners?
Currently, no hedge funds are holding shares in PIII
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
P3 Health Partners
P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. The company is based in Henderson, Nevada.
PIII Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted several positive developments, including increased capitated revenue, successful operational improvements, strategic ventures, and reduced operating expenses. However, these are counterbalanced by significant adjusted EBITDA losses and revised financial guidance, indicating ongoing financial challenges.View all PIII earnings summariesPIII Stock 12 Month Forecast
Average Price Target
$10.25
▲(148.79% Upside)